glp 1 celiac GLP-1 Frontiers | Glucagon-like peptide-1: a
Description
Link to full post: GLP-1 Drugs, Digital Health & Obesity Trends in 2026Overweight and obesity are driving a booming digital health market through telehealth, wearables, and new pharma-to-consumer models.I've been reporting on this space in my #Trends report since March 2024two years ago (Navigating Obesity Care in the Digital Age)

This performance reflects unprecedented demand despite earlier supply constraints and sets the stage for pricing and reimbursement debates as the market matures

sales of GLP-1 drugs were $13.7 billion.

What to expect while on GLP-1 treatment

Glucagon-like peptides (GLP-1 and GLP-2) are two proglucagon-derived intestinal hormones that mediate distinct physiological functions through two related receptors (GLP-1R and GLP-2R) which are important drug targets for metabolic disorders and Crohns disease, respectively
Despite eating healthy and working out, lasting weight loss
